Jazz Pharmaceuticals
JAZZ
#1528
Rank
C$20.48 B
Marketcap
C$326.41
Share price
1.69%
Change (1 day)
124.82%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Total debt

Total debt on the balance sheet as of March 2026 : C$7.68 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's total debt is C$7.68 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Jazz Pharmaceuticals - Total debt on balance sheet (from 2005 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$7.42 B-16%
2024-12-31C$8.84 B15.12%
2023-12-31C$7.68 B-2.6%
2022-12-31C$7.88 B0.58%
2021-12-31C$7.84 B173.41%
2020-12-31C$2.86 B23.98%
2019-12-31C$2.31 B6.38%
2018-12-31C$2.17 B9.4%
2017-12-31C$1.98 B-27.12%
2016-12-31C$2.72 B65.44%
2015-12-31C$1.64 B5.83%
2014-12-31C$1.55 B166.1%
2013-12-31C$0.58 B28.9%
2012-12-31C$0.45 B
2010-12-31C$48.02 M-63.27%
2009-12-31C$0.13 B-12.15%
2008-12-31C$0.14 B89.88%
2007-12-31C$78.38 M-11.96%
2006-12-31C$89.03 M3.87%
2005-12-31C$85.72 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
C$66.69 B 767.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
C$7.12 B-7.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
C$7.22 M-99.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
C$23.99 B 212.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel